Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Intraocular Lymphoma 1

Interventions

Rituximab 15 Cyclophosphamide 15 Peripheral Blood Stem Cell Transplantation 14 fludarabine phosphate 11 Whole-Body Irradiation 11 Mycophenolic Acid 8 Etoposide 8 Methotrexate 7 Filgrastim 7 Cyclosporine 7 Lenalidomide 6 Dexamethasone 6 Busulfan 6 Tacrolimus 5 Radiotherapy 5 Cytarabine 5 Carboplatin 5 Thiotepa 4 Melphalan 4 Transplantation 3 Therapeutics 3 Granulocyte Colony-Stimulating Factor 3 Flow Cytometry 3 Calcium Dobesilate 3 Bortezomib 3 Antilymphocyte Serum 3 pegfilgrastim 2 etoposide phosphate 2 Psychiatric Rehabilitation 2 Polymerase Chain Reaction 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Intraocular Lymphoma × Lens Implantation, Intraocular × Clear all

NCT03157375 2017-05-17

Rot P261

Medical University of Vienna

Phase NA Completed

Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡